TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in information processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h free fatty acid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-h C-peptide concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Weight gain post-randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length gain till 40 weeks of gestational age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Best-corrected visual acuity (BCVA) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PRQLQ scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: nPEFR (nocturnal Peak Expiratory Flow Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Functional independence after 6 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: New intracerebral hemorrhages
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of perineal wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative fatigue
Endpoint domain: Adverse events/effects
Primary endpoint: Toxicities precluding completion of adjuvant therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Complete symptomatic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average of the green zone days ('doing well')
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of cervical spine range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in pain intensity (PI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in pressure pain threshold (PPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: loudness of hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in density of key pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction in proportions of spirochetes and motile organisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of colony-forming units/ml of black-pigmented bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: reductions in alcohol-related problems
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Hallux valgus angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hallux pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective ocular discomfort scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: size of epithelial defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in disease management outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean AUC of nisoldipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of nisoldipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of metabolite M9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean operation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk of pelvic infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Alzheimer's Disease Cooperative Study‐Activities of Daily Living (ADCS‐ADL) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean FD value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: GMFM-66 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEDI-Functional Skills Self-Care and Mobility improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Class III and IV heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of treatment completers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of CIN2-3/AIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pain thresholds to electrical stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain thresholds to pressure stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean WTI in myocardial segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: major CVD events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of atrial capture during PN pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KAH scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival without grade 3 or 4 drug-related toxicity
Endpoint domain: Mortality/survival
Primary endpoint: Survival without grade 4 drug-related toxicity
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of H. pylori infection
Endpoint domain: Adverse events/effects
Primary endpoint: Averaged area under the ROC curve (Az) for detecting infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Averaged area under the ROC curve (Az) for detecting DWMH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mechanical dynamic allodynia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: static mechanical allodynia/hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction in terms of cosmesis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: white spot lesion formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall ARI antibiotic prescribing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: non-antibiotic-appropriate ARI prescribing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF-receptor I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: systemic arterial stiffness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: elevated high-density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Significant pain relief and functional status improvement of 50% or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: O(2) desaturation associated with gastroesophageal reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: prostate cancer-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: survival free of salvage AST
Endpoint domain: Mortality/survival
Primary endpoint: Likelihood of receiving antiestrogen therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Radiographic recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: serum valproic acid level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean IOP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAILS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SF-36 physical
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SF-36 mental
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: COPM performance scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: COPM satisfaction scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Annualized rate of symptom-defined exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first symptom-defined exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medial patellar-femoral cartilage damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft status (excellent vs poor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Students' achievement of clinical competencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma corticotropin‐releasing hormone immunoreactivity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ever screened for CRC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Being up to date for CRC screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aldrete recovery score ≥9 duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (QOL) in social function
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Quality of Life (QOL) in general health perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in tension scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: whole-day mean blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: whole-day mean median arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean pain relief (PR) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pain intensity difference (PID) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall failure rate (persistence plus relapse)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Intrarater and interrater agreement for tweet categorization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambient nicotine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of the health effects of SHS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-reported SHS exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with nodules decreased in size by more than 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rates of benign nodular goiter after total thyroidectomy
Endpoint domain: Mortality/survival
Primary endpoint: Rate of transient hypocalcemia after total thyroidectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Bacterial eradication rates of respiratory pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cumulative intake minus output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fall rates
Endpoint domain: Mortality/survival
Primary endpoint: time spent exercising
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in WHO Wellbeing Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: self-reported kerosene-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: kerosene-related safety practices
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: recognition of kerosene injury risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pao(2)/Fio(2) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: postoperative ventilation times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospital stays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRT use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity and incidence of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Case-fatality rate
Endpoint domain: Mortality/survival
Primary endpoint: Mean duration of coma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intended treatment choice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-management skill
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total IGF‐I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Acid-labile subunit levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Duration of neuromuscular blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of respiratory distress syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: wasted ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rates of continuous extubation for 120 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Duration of extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Peak inspiratory pressures (PIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: radiographic Progression-Free Survival (rPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Grade 3 or 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Delayed complete protection (CP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOD content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reactance area (XA) from impulse oscillometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: IIEF EF normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSV improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rates after reperfusion therapy
Endpoint domain: Mortality/survival
Primary endpoint: improvement in measured parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in reticulocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Delayed recall improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Degree of spasticity of the plantar flexor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Stratum Corneum (SC) thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Water content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Natural Moisturizing Factor (NMF) content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: VO2 uptake after exercise training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptability of the Brief targeted prevention intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: completion of counseling session in the PED
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: delay in onset of alcohol use in teens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of asthma episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Physician/clinic visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of performance measures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Survival rate for ceramic crowns and FPDs
Endpoint domain: Mortality/survival
Primary endpoint: Medication review completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulty to chew
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehension scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of CT infarcts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: EQ-5D-5L health states values
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: general quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in symptoms of osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Absolute bioavailability of repaglinide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractional oral exhaled nitric oxide (FeNO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Nasal eosinophilic cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Visual analogue scale for allergic symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 18F‐NaF uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 18F‐FDG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient assessment of overactive bladder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NO concentration in the urinary bladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: per-protocol eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intention-to-treat eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-cell immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody immune responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Local reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Asthma control test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete clearance of detectable microfilariae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bingeing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minor bleeding incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Therapist's rating of a child's functional communication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disruption of the blood-aqueous barrier
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postlaser pain
Endpoint domain: Adverse events/effects
Primary endpoint: Total health care consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increase in plasma arginine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in plasma citrulline levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in TAS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete ST resolution at 90 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total mortality rate at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Fever resolution rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Culture contamination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of non-invasive ventilation (NIV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RASS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory discomfort (visual analog scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SleepEE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: suicidality
Endpoint domain: Adverse events/effects
Primary endpoint: Beck Depression Inventory ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes